HomeBiotech

Biotech

Renovos Biologics strengthens its Board’s US expertise with the appointment of Lisa Ferrara, Ph.D., as a Non-Executive Director

Renovos Biologics strengthens its Board’s US expertise with the appointment of Lisa Ferrara, Ph.D., as a Non-Executive Director

September 19, 2024

Sirnaomics Announces Demonstration of a Novel Mechanism of Action of Its siRNA Therapeutics for Focal Fat Reduction in Journal of Cosmetic Dermatology

Sirnaomics Announces Demonstration of a Novel Mechanism of Action of Its siRNA Therapeutics for Focal Fat Reduction in Journal of Cosmetic Dermatology

September 19, 2024

TFS HealthScience Unveils Mission to Empower Partners and Enrich Lives Worldwide

TFS HealthScience Unveils Mission to Empower Partners and Enrich Lives Worldwide

September 19, 2024

Clarivate Announces 15th Annual Pharmavision India Conference Agenda

Clarivate Announces 15th Annual Pharmavision India Conference Agenda

September 18, 2024

Biosyngen’s first-in-class CAR-T asset targeting solid tumors has entered pivotal phase II trial, Phase I trial data debut at ESMO 2024 Annual Congress

Biosyngen’s first-in-class CAR-T asset targeting solid tumors has entered pivotal phase II trial, Phase I trial data debut at ESMO 2024 Annual Congress

September 18, 2024

Nuvalent Announces Pricing of Upsized Public Offering of Common Stock

Nuvalent Announces Pricing of Upsized Public Offering of Common Stock

September 17, 2024

Subgroup Analysis from Pivotal WU-KONG1B Study Exhibits Robust Efficacy of Sunvozertinib in Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations Across Different Baseline Characteristics

Subgroup Analysis from Pivotal WU-KONG1B Study Exhibits Robust Efficacy of Sunvozertinib in Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations Across Different Baseline Characteristics

September 17, 2024

Monument Therapeutics Announces Grant of UK Patent for Neuroinflammation Compound MT1980

Monument Therapeutics Announces Grant of UK Patent for Neuroinflammation Compound MT1980

September 17, 2024

Remedee Labs’ Solution becomes the first CE marked medical device (class IIa) approved for the treatment of fibromyalgia in Europe

Remedee Labs’ Solution becomes the first CE marked medical device (class IIa) approved for the treatment of fibromyalgia in Europe

September 16, 2024

Antennova Releases Latest Data of CD73 Inhibitor ATN-037, including a DCR of 89.5%, in a Mini Oral at ESMO Congress 2024

Antennova Releases Latest Data of CD73 Inhibitor ATN-037, including a DCR of 89.5%, in a Mini Oral at ESMO Congress 2024

September 16, 2024

« 1 … 13 14 15 16 17 … 75 »